Clinical Trial Update: A Phase 1/2 Study of SC-43 in Combination With Cisplatin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study investigating SC-43 in combination with cisplatin in advanced cancers including non-small cell lung cancer and biliary tract cancer; status curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• SC-43

Snippet

Sponsor: RaND Biosciences | Conditions: Advanced Non-small-cell Lung Cancer, Advanced Biliary Tract Cancer | Phase 1, Phase 2 | Status: UNKNOWN